AU2003201688A1 - Fibronectin variants and screening methods - Google Patents

Fibronectin variants and screening methods

Info

Publication number: AU2003201688A1
Authority: AU; Australia
Prior art keywords: screening methods; fibronectin variants; fibronectin; variants; screening
Prior art date: 2002-01-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003201688A

Other languages

English (en)

Inventor

David Barlow

Helen Mardon

Ian Sargent

Christopher Van De Walle

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Oxford University Innovation Ltd

Original Assignee

Oxford University Innovation Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-21

Filing date

2003-01-21

Publication date

2003-09-02

2003-01-21 Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd

2003-09-02 Publication of AU2003201688A1 publication Critical patent/AU2003201688A1/en

Status Abandoned legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Hematology (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Reproductive Health (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Toxicology (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2003201688A 2002-01-21 2003-01-21 Fibronectin variants and screening methods Abandoned AU2003201688A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0201273.0		2002-01-21
GBGB0201273.0A GB0201273D0 (en)	2002-01-21	2002-01-21	Fibronectin variants and screening methods
PCT/GB2003/000212 WO2003062830A2 (fr)	2002-01-21	2003-01-21	Variants de fibronectine et methodes de criblage associees

Publications (1)

Publication Number	Publication Date
AU2003201688A1 true AU2003201688A1 (en)	2003-09-02

Family

ID=9929422

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003201688A Abandoned AU2003201688A1 (en)	2002-01-21	2003-01-21	Fibronectin variants and screening methods

Country Status (3)

Country	Link
AU (1)	AU2003201688A1 (fr)
GB (1)	GB0201273D0 (fr)
WO (1)	WO2003062830A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2670471A1 (fr)	2006-11-22	2008-06-05	Adnexus, A Bristol-Myers Squibb R&D Company (A Delaware Corporation)	Substances therapeutiques a base de proteines modifiees ciblees sur des recepteurs de tyrosine kinases, dont l'igf-ir
FR2976587B1 (fr) *	2011-06-20	2015-04-03	Basf Beauty Care Solutions F	Methode de dosage in vitro par technique immunologique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8516421D0 (en) *	1985-06-28	1985-07-31	Biotechnology Interface Ltd	Fibronectins
EP0513345A4 (en) *	1990-12-04	1994-09-14	Sinai School Medicine	Therapeutic and diagnostic applications of fetal fibronectin

2002
- 2002-01-21 GB GBGB0201273.0A patent/GB0201273D0/en not_active Ceased
2003
- 2003-01-21 WO PCT/GB2003/000212 patent/WO2003062830A2/fr not_active Ceased
- 2003-01-21 AU AU2003201688A patent/AU2003201688A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2003062830A3 (fr)	2004-03-04
WO2003062830A2 (fr)	2003-07-31
GB0201273D0 (en)	2002-03-06

Publication	Publication Date	Title
AU2003214977A1 (en)	2003-09-02	Glaucoma screening system and method
AU2003226094A1 (en)	2003-10-13	Compounds and methods
AU2003296064A1 (en)	2004-07-29	Circular-cylinder sieve
AU2003268032A1 (en)	2004-02-16	Composition and methods for treatment and screening
AU2002351206A1 (en)	2004-06-23	Lateral lubistor structure and method
AU2003277663A1 (en)	2004-06-03	Screening method
AU2002303230A1 (en)	2003-10-20	Combined hydrotreating and process
AU2003242340A1 (en)	2003-12-31	Novel screening method
GB0418824D0 (en)	2004-09-22	Screening process
AU2003302173A1 (en)	2004-07-14	Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003201688A1 (en)	2003-09-02	Fibronectin variants and screening methods
AU2003227268A1 (en)	2003-10-13	Novel screening method
AU2003286392A1 (en)	2004-06-18	1microarrays and production thereof
AU2002348807A1 (en)	2003-05-15	Screening method which uses BNPI and DNPI
AU2003303311A1 (en)	2004-08-30	Methods for selecting and screening for trasformants
AU2003242342A1 (en)	2004-02-02	Novel screening method
AU2003273152A1 (en)	2003-12-12	Receptor and screening methods
AU2003217008A1 (en)	2003-09-29	Screening method
GB0206657D0 (en)	2002-05-01	Novel intermediate and process
AU2003248955A1 (en)	2004-02-09	Screening method
AU2003235310A1 (en)	2003-11-03	Novel screening method
AU2003223357A1 (en)	2003-10-13	Compounds and methods
AU2003235120A1 (en)	2003-11-10	Screening method
AU2002952433A0 (en)	2002-11-21	Screening method
AU2003280725A1 (en)	2004-06-03	Screening method

Legal Events

Date	Code	Title	Description
2004-10-07	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase